
Reset all filters
01 2Blake Cassels & Graydon LLP
02 2Gowling WLG
Reset all filters
01 12373794
02 12428160
03 12520979
04 12582452
Reset all filters
01 4Trabectedin
Reset all filters
01 4Powder for solution
Reset all filters
01 12020-05-15
02 12021-11-06
03 12025-10-26
04 12025-10-27
Patent Expiration Date : 2025-10-26
Date Granted : 2010-09-07
Brand Name : YONDELIS
Patent Number : 2582452
Filing Date : 2005-10-26
Strength per Unit : 1 mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2025-10-26
Date Granted : 2010-09-07
Patent Expiration Date : 2021-11-06
Date Granted : 2009-10-13
Brand Name : YONDELIS
Patent Number : 2428160
Filing Date : 2001-11-06
Strength per Unit : 1 mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2021-11-06
Date Granted : 2009-10-13
Patent Expiration Date : 2025-10-27
Date Granted : 2009-03-24
Brand Name : YONDELIS
Patent Number : 2520979
Filing Date : 2005-10-27
Strength per Unit : 1 mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2025-10-27
Date Granted : 2009-03-24
Patent Expiration Date : 2020-05-15
Date Granted : 2005-10-11
Brand Name : YONDELIS
Patent Number : 2373794
Filing Date : 2000-05-15
Strength per Unit : 1 mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-05-15
Date Granted : 2005-10-11